Newsbenzinga
Vanda Pharmaceuticals Announces European Medicines Agency Adopts Positive Opinion For Orphan Drug Designation Of Imsidolimab For Generalized Pustular Psoriasis
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…